Accelerating Longer Lasting Efficacy & Less Invasive Retinal Drug Delivery to the Clinic

January 30-February 1, 2024 | San Francisco, CA

The Definitive Industry Forum for Longer Lasting & Less Invasive Delivery to the Retina

The 2nd Annual Next Generation Ophthalmic Drug Delivery Summit is returning to San Francisco this January to unite 90+ device engineers, biochemists, preclinical and clinical experts as they discuss how they are optimizing longer-lasting and less invasive delivery to the back of the eye to reduce patient concerns and burden on healthcare systems caused by frequent drug administration.

Join 23+ expert speakers from the likes of AbbVie, Boehringer Ingelheim, Bayer, Genentech, Janssen, Novartis, and Clearside Biomedical at the only industry-dedicated event focusing on overcoming key translational challenges of developing and implementing novel delivery technology as they progress their ophthalmic pipelines to the clinic.


Full Event Guide Front Page

Attending Companies Include:

Janssen Iveric Bio Genentech Abbvie and Novartis
OcuTerra, Bayer, Clearside Biomedical, Boehringer Ingelheim, Regeneron
Oculis, Opus Genetics, Nanoscope Therapeutics, Ocugen, Oxular

Wold-Class Speaker Faculty Includes:

Proud to Partner with:


Hear Why Your Industry Peers are Excited to Attend:

“I see tremendous value in participating in events such as the Next Generation Ophthalmic Drug Delivery Summit as it gives us the opportunity to network, be inspired and find areas of potential collaboration with colleagues who are working towards a similar objective of improving sights and improving eye care.”

Riad Sherif, Chief Executive Officer, Oculis


Other Events in the Ophthalmology & Sensory Series: